| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 20.05▲ | 20.04▲ | 20.02▲ | 19.58▲ | 19.23▲ |
| MA10 | 20.05▲ | 20.02▲ | 20.00▲ | 19.63▲ | 18.63▲ |
| MA20 | 20.02▲ | 20.02▲ | 19.82▲ | 19.07▲ | 19.07▲ |
| MA50 | 20.07▼ | 19.68▲ | 19.59▲ | 18.71▲ | 17.24▲ |
| MA100 | 20.02▲ | 19.62▲ | 19.53▲ | 19.13▲ | 15.48▲ |
| MA200 | 19.74▲ | 19.40▲ | 18.61▲ | 17.63▲ | 13.85▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.005▲ | -0.021▼ | 0.013▲ | 0.073▲ | -0.033▼ |
| RSI | 54.587▲ | 57.457▲ | 63.375▲ | 67.212▲ | 59.234▲ |
| STOCH | 40.758 | 39.918 | 35.995 | 43.513 | 51.510 |
| WILL %R | -63.636 | -61.739 | -45.223 | -22.843▲ | -24.823▲ |
| CCI | 74.286 | 15.437 | 76.956 | 123.959▲ | 65.486 |
|
Tuesday, June 23, 2026 05:07 PM
Merck remains in focus after important pipeline developments, new product approvals, and clinical progress strengthen discussions around future business growth and valuation.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/06/26 | 19.90 | 20.44 | 19.895 | 20.05 | 114,631 |
| 24/06/26 | 19.74 | 20.05 | 19.62 | 19.86 | 201,984 |
| 23/06/26 | 19.18 | 19.62 | 18.62 | 19.55 | 245,100 |
| 22/06/26 | 19.30 | 19.545 | 19.155 | 19.18 | 83,448 |
| 18/06/26 | 19.50 | 19.70 | 19.14 | 19.25 | 167,972 |
| 17/06/26 | 19.66 | 20.00 | 18.97 | 19.27 | 101,283 |
| 16/06/26 | 20.01 | 20.32 | 19.445 | 19.68 | 107,312 |
| 15/06/26 | 20.10 | 20.50 | 19.55 | 19.74 | 123,063 |
| 12/06/26 | 19.90 | 20.19 | 19.90 | 19.96 | 89,030 |
| 11/06/26 | 19.63 | 19.85 | 19.50 | 19.75 | 113,092 |
|
|
||||
|
|
||||
|
|